New Study Shows COVID-19 Breakthroughs Don't Affect HIV Immune Status
最新研究顯示，新冠疫苗突破性感染不會影響愛滋病毒（HIV）的免疫狀態
更新於: 2026年6月15日 上午12:45
A recent study from the CIVET-II cohort brings reassuring news for people living with HIV (PWH).
一項來自CIVET-II隊列的最新研究，為愛滋病病毒感染者(PWH)帶來了令人放心的消息。
Researchers evaluated how COVID-19 breakthrough infections affect CD4 T-cell counts—a key indicator of immune health—in vaccinated individuals.
研究人員評估了COVID-19突破性感染如何影響已接種疫苗者的CD4 T細胞計數，這是衡量免疫健康的一項關鍵指標。
The findings indicate that while breakthrough infections can occur, they do not lead to a long-term or clinically significant decline in CD4 counts.
研究結果顯示，雖然突破性感染仍可能發生，但並不會導致CD4細胞計數出現長期或臨床上顯著的下降。
Although minor fluctuations may happen immediately after infection, data shows a consistent rebound in immune cells within two months, confirming the immune system's ability to recover.
儘管感染後可能會立即出現輕微的波動，但數據顯示免疫細胞會在兩個月內穩定反彈，證實了免疫系統的復原能力。
However, this study also highlights the importance of ongoing clinical caution.
然而，這項研究也強調了持續保持臨床謹慎的重要性。
Research consistently shows that individuals with HIV are more susceptible to contracting breakthrough COVID-19 infections than the general population.
研究一致表明，與一般人群相比，愛滋病病毒感染者更容易感染突破性COVID-19。
Furthermore, those with lower CD4 counts face a higher risk of severe illness if infected.
此外，CD4計數較低者若受到感染，面臨重症的風險更高。
Therefore, medical experts continue to emphasize that, while the virus may not permanently damage the immune status of treated patients, vaccination remains the most critical defense.
因此，醫學專家持續強調，雖然病毒可能不會永久損害接受治療患者的免疫狀態，但疫苗接種仍然是最關鍵的防禦手段。
Staying up-to-date with vaccine doses is essential for PWH to prevent severe disease and hospitalization, balancing the reality of increased infection risk with the proven efficacy of modern medical interventions.
對愛滋病病毒感染者而言，及時接種疫苗對於預防重症和住院至關重要，在感染風險增加的現實與現代醫療介入已證實的功效之間取得平衡。
